Intertek to Speak, Present and Exhibit at SOT 2017

February 15, 2017

Ontario, Canada - Intertek, the leading provider of quality and safety services to industries worldwide and Health, Environmental and Regulatory Services (HERS), is pleased to announce that they will be attending the Society of Toxicology (SOT) Annual Meeting in Baltimore, Maryland from March 12-16, 2017 and during which will be involved in a variety of workshops, exhibitor hosted sessions and research posters.

Intertek expert Ms. Lois Haighton, Director, Food & Nutrition Group will co-chair a workshop titled, “Scientific, Regulatory, and Safety Considerations for Probiotics and Microbiome Targeted Therapeutics” on Monday March 13, 2017 from 9:30 am – 12:15 pm. The guidelines for these products are not harmonized, across the different product categories or between different jurisdictions; thus, making the relevant regulatory path difficult to navigate. During this workshop, Dr. Alexandra Lobach, Manager-Toxicology, Food & Nutrition Group will also be presenting on “Understanding the Safety Requirements and Regulatory Hurdles of Different Product Classes Containing Probiotics”.

Additionally, Intertek will be hosting two exhibitor sessions:

  • Tuesday, March 14 (4:30 - 5:30 pm):
    Challenges in Developing Ocular Drugs from a Bioanalytical and Toxicological Perspective
    Presenters: Jamil Hantash, MSc, MBA, Vice President, Intertek Pharmaceutical Services USA; and Lindsay N. Donald, DABT, Vice President, Pharmaceutical & Healthcare, Intertek Scientific & Regulatory Consultancy
    Details: Ocular drugs are challenging to develop from bioanalytical, analytical and toxicological perspectives. This presentation will provide ways to help face these challenges and review regulatory requirements.
  • Wednesday, March 15 (12:00 - 1:00 pm):
    How to Provide Meaningful Analytical Data for the Toxicologist to Assess Inhalation-based Medical Devices: Analytical and Toxicology Perspective
    Presenters: Gyorgy Vas, PhD, Business-Technical Scientific Liaison, Intertek Pharmaceutical Services; and Hana Fikree, MSc, DABT, Manager, Toxicology, Pharmaceuticals & Healthcare, Intertek Scientific & Regulatory Consultancy
    Details: Due to gas environment exposure, analytical testing for inhalation-based medical devices is challenging. We will present analytical approaches to address these challenges and provide alternatives required for toxicological assessments.

During the event attendees are invited to attend posters sessions.  These posters sessions provide first-hand knowledge of the latest research and advances. Intertek’s posters are titled:

  • Wednesday, March 15 (1:15 – 4:30 pm), CC Exhibit Hall or Hall A:
    Evaluating the Hypersensitivity Potential of Propylene Glycol in Small Molecule Parenteral Formulations
    (Presenter: Joanne Wan)
  • Tuesday, March 14 (9:30 am – 12:45 pm), CC Exhibit Hall or Hall A:
    Toxicological Assessment of Benzyl Chloride as a Topical Ophthalmic Drug Product Impurity 
    (Presenter: Hana Fikree)
  • Wednesday, March 15 (9:30 am – 12:45 pm), CC Exhibit Hall or Hall A:
    Alternative Approach in the Safety Assessment of Plant-Based Proteins for Use as Novel Ingredients in Food 
    (Presenter: Kerry Finch)

During SOT, representatives from Intertek’s pharmaceutical team will also be available for consultation at booth #2050. SOT attendees are encouraged to stop by the Intertek booth to discuss their company’s specific requirements.

To learn more about our services for a wide range of pharmaceuticals, biopharmaceuticals, food and supplement products and the larger Intertek organization, please visit http://www.intertek.com/pharmaceutical/.
 

 

About Intertek
Intertek is a leading Total Quality Assurance Provider to industries worldwide. Our network of more than 1,000 laboratories and offices and over 40,000 people in more than 100 countries, delivers innovative and bespoke Assurance, Testing, Inspection and Certification solutions for our customers’ operations and supply chains.

www.intertek.com

Bringing quality and safety to life.

 

For Scientific & Regulatory Consulting Inquiries:
Lois Haighton, B.Sc., DABT, ERT
Director
Intertek Scientific & Regulatory Consultancy
Telephone: 905-542-2900
Email: lois.haighton@intertek.com

For Pharmaceutical Testing Inquiries:
Lori Payne, PhD
Director, Business Development
Intertek Pharmaceutical Services
Telephone: 858-226-0248
Email: lori.payne@intertek.com

For Media Inquiries: 
Tracy Veale 
Marketing Manager
Global Health, Environmental & Regulatory Services
Intertek
Direct: 905-286-4182 
Email: tracy.veale@intertek.com